SlideShare a Scribd company logo
1 of 64
NAFLD , Chronic HCV and DM
Multisystem systemic diseases with hepatic flavor
Non-alcoholic fatty liver disease, hepatitis C virus infection and type 2 diabetes: the “vicious circle”. The
liver plays a pathogenic role in the development of type 2 diabetes both in the context of
non-alcoholic fatty liver disease and hepatitis C virus infection through the development of systemic
and hepatic insulin resistance, partly mediated by the release of multiple pro-inflammatory cytokines,
diabetogenic hepatokines and reactive oxygen species. If left uncorrected, insulin resistance will
eventually lead to progressive pancreatic beta cell failure in predisposed individuals. Moreover, the
strong interconnection between type 2 diabetes and liver disease may result into a “vicious circle”
[25] eventually leading to liver disease progression with an excess risk of liver-related, i.e., cirrhosis
and hepatocellular carcinoma (HCC), and cardiovascular complications, i.e., atheroscler
Review
Type 2 Diabetes in Non-Alcoholic Fatty Liver
Disease
and Hepatitis C Virus Infection—Liver: The
“Musketeer” in the Spotlight
Stefano Ballestri 1, Fabio Nascimbeni 2,3, Dante
Romagnoli 2, Enrica Baldelli 3,
Giovanni Targher 4 and Amedeo Lonardo 2,*
Received: 16 February 2016; Accepted: 2 March
2016; Published: 9 March 2016
Nutritional Management for
GORD
Dr Abdel Rahman A Mokhtar
Professor Internist & Gastroenterolgist
Mansoura University
EGYPT
2016
Our understanding of the
pathogenesis, clinical spectrum and
epidemiology of GORD has
continuously evolved.
Historicaly
At first, reflux was synonymous with oesophagitis and
hiatus hernia.
Then, it was a motility disorder, defined by sphincter or
peristaltic dysfunction.
Next, it was an acid-peptic disorder.
Now, we see GORD emerging as a heterogeneous entity
encompassing elements of all these concepts
These developments
prompted the formation
of an international
consensus conference,
resulting in the
‘Montreal definition’ of GORD.
Cowen, S. G. Therapeutic Categories Outlook (SG Cowen,2005)
While typical GERD symptoms are balanced between comparator groups, the distribution of
complications becomes progressively skewed in gender, geographic and racial distribution.
*GORD symptoms are similar between Western and Middle Eastern countries, but are lower in
Eastern countries.
Epidemiological trends in GORD-related disorders.
PATHOPHYSIOLOGY
The earlier belief that increased gastro
esophageal reflux mainly results from
one dominant mechanism has been
replaced by acceptance that GORD is
multifactorial
| Possible gastroesophageal reflux disease pathophysiologies
AT Cellular level :
Exposure of the oesophageal
wall to the refluxate results in :
a | An inflammatory response occurs in the squamous
epithelium, induced by the release of inflammatory
mediators, which
b | Leads to the subsequent chemoattraction and infiltration
of immune cells and is
c | Followed by the proliferative
response of the epithelium..
Kandulski, A. & Malfertheiner, P. Nat. Rev. Gastroenterol. Hepatol. 9,
15–22 (2012);
So , it is not that simple
THREE ROLES
Body
weight
Gut
microbiota
Firing
foods
OBESITY
Gastroesophageal Pressure Gradients & GERD:
The Importance of Obesity
From de Vries DR et al. Am J
Gastroenterol 2008;103:1349-54.
Optimizing body weight is a must
GUT MICROBIOTA
The intestinal microbiota lies strategically at the interface of the internal and external
environment of the gut.
It plays several important biological roles including: aiding in digestion and absorption of
nutrients from partially digested food, production of SCFA – a primary energy source for
intestinal epithelial cells (IECs), stimulating immune responses by releasing ligands, and
protection against enteropathogens by production of antimicrobial peptides (AMPs)
Factors affecting gut microbiota
Is dysbiosis of the upper-GI tract to blame for
esophageal gastroesophageal reflux disease
(GERD) and it’s related conditions, Barrett’s
esophagus and adenocarcinoma?
Undoubtedly, we need to eradicate virulent H. pylori in
people with adverse clinical manifestations, but this
conclusion cannot be generalized to all H. pylori positive
subjects.
For the past four years we’ve known
that individuals with GERD have imbalances in
the microbial ecology of the distal esophagus.
One consequence of this microbial shift is increased
levels of Gram-negative bacteria, which harbor on
their cell surface an inflammatory membrane
component known as lipopolysaccharides (LPS)
or endotoxin
Clinical and Translational Gastroenterology (2015) 6, e91; doi:10.1038/ctg.2015.16; published online 18 June 2015
Type1-microbiota (Gram-positive predominant) with H. pylori provides a neutral esophageal
environment. Type-II microbiota (Gram-negative predominant) with loss of H. pylori invokes a
pro-inflammatory state in two ways. First, loss of H. pylori allow for increased acid secretion
resulting in gastroesophageal reflux disease and its sequelae. Second, predominance of Gram-
negative bacteria upregulate the pro-inflammatory cascade due to the
interaction between lipopolysaccharide and Toll-like receptor 4.
Gut microbiota & esophageal adenocarcinoma.
Microbiota and its influence on obesity.
Probiotics, Prebiotics and Symbiotics
Probiotics are defined as live microorganisms which
confer health benefits to the host when taken in adequate
quantities.
Prebiotics are nondigestible food ingredients that beneficially
affect the host by selectively stimulating the growth
and/or activity of beneficial colonic bacteria.
Acombination of probiotics and prebiotics is termed symbiotics.
Various kinds of probiotics have been tested clinically as potential therapeutic
agents for both localized and systemic diseases.
Should dietary guidelines consider
microbiota needs ???
Potential therapeutic window
STOP Firing foods
It is a common belief that some foods may induce
or worsen GERD symptoms; in fact, in daily clinical
practice, this belief leads to advising patients to avoid
the suspect foods .
Further more, since GERD symptoms are most commonly
reported postprandially, the role of diet components in inducing
symptoms has been suggested.
However, different and conflicting results exist in the literature
for identifying the most “refluxogenic” foods
Festi etal.,World J Gastroenterol April 14, 2009
Dietary elements may ppt reflux episode via :
Increasing acid secretion e.g Coffee.
Decrease LOS pressure e.g peppermint & ess oils.
Slow gastric emptying e.g fatty food .
Impairing oesophageal motility e.g alcohol.
Triggering pain by irritating an already inflammed oesophageal
mucosa e.g Tomato, citrus, softdrinksandspicyfood.
Foods Not Recommended
It is recommended that a trial of limiting or eliminating the following foods may
reduce the symptoms of GERD:
• Peppermint and spearmint
• Chocolate
• Alcohol
• Caffeinated beverages (regular tea, coffee, colas, energy drinks, other caffeinated
soft drinks)
• Decaffeinated coffee and decaffeinated regular tea (herbal teas, except those with
peppermint or spearmint, are allowed)
• Pepper
• High-fat foods, including:
o 2% milk, whole milk, cream, high-fat cheeses, high-fat yogurt, chocolate milk,
cocoa
o Fried meats, bacon, sausage, pepperoni, salami, bologna, frankfurters/hot dogs
o Other fried foods (doughnuts, french toast, french fries, deep-fried vegetables)
o Nuts and nut butters
o Pastries and other high-fat desserts
o More than 8 teaspoons of oil, butter, shortening per day
• Any fruits or vegetables that cause symptoms. (These will vary from person to
person.)
American Dietetic Association.
Other Lifestyle Tips
• Exercise at least three or four times each week.
• Wear loose-fitting clothes.
• Do not smoke.
• Raise the head of your bed 6 to 9 inches. You can put a foam wedge
under the top part of the mattress, or prop up the legs on the head of the
bed with wooden blocks. (Stacking pillows is not effective.)
• Wait 3 hours after eating before lying down.
• Eat several small meals throughout the day.
• Eat in a calm, relaxed place. Sit down while you eat.
To Conclude
Weight
control
Healthy
microbiota
Avoid diets ppt
reflux episodes
Thank You

More Related Content

Similar to HCV & Diabetes Mellitus lecture about link.pptx

Diseases of small intestine (1)بور .pptx
Diseases of small intestine (1)بور .pptxDiseases of small intestine (1)بور .pptx
Diseases of small intestine (1)بور .pptx
ssuser43edbb
 
21 ulcerative colitis
21 ulcerative colitis21 ulcerative colitis
21 ulcerative colitis
internalmed
 
Hígado graso no alcohólico en niños y adolescentes obesos
Hígado graso no alcohólico en niños y adolescentes obesosHígado graso no alcohólico en niños y adolescentes obesos
Hígado graso no alcohólico en niños y adolescentes obesos
Cuerpomedicoinsn
 
Steatosis and hcv__as published
Steatosis and hcv__as publishedSteatosis and hcv__as published
Steatosis and hcv__as published
Shendy Sherif
 

Similar to HCV & Diabetes Mellitus lecture about link.pptx (20)

Ibd pptx.
Ibd pptx.Ibd pptx.
Ibd pptx.
 
Medicine 5th year, all lectures/diabetes mellitus (Dr. Taha Mahwy)
Medicine 5th year, all lectures/diabetes mellitus (Dr. Taha Mahwy)Medicine 5th year, all lectures/diabetes mellitus (Dr. Taha Mahwy)
Medicine 5th year, all lectures/diabetes mellitus (Dr. Taha Mahwy)
 
28 - IBD.ppt
28 - IBD.ppt28 - IBD.ppt
28 - IBD.ppt
 
Nutrition and Gastrointestinal tract
Nutrition and Gastrointestinal tractNutrition and Gastrointestinal tract
Nutrition and Gastrointestinal tract
 
Ulcerative Colitis
Ulcerative ColitisUlcerative Colitis
Ulcerative Colitis
 
Diabetes mellitus
Diabetes  mellitusDiabetes  mellitus
Diabetes mellitus
 
Approach to Malabsorption syndromes for undergraduates
Approach to Malabsorption syndromes for undergraduatesApproach to Malabsorption syndromes for undergraduates
Approach to Malabsorption syndromes for undergraduates
 
Diarrhea in cancer patients
Diarrhea in cancer patientsDiarrhea in cancer patients
Diarrhea in cancer patients
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Chronical pancreatities
Chronical pancreatitiesChronical pancreatities
Chronical pancreatities
 
celiac disease
celiac diseaseceliac disease
celiac disease
 
Diseases of small intestine (1)بور .pptx
Diseases of small intestine (1)بور .pptxDiseases of small intestine (1)بور .pptx
Diseases of small intestine (1)بور .pptx
 
Crohn’s disease
Crohn’s diseaseCrohn’s disease
Crohn’s disease
 
21 ulcerative colitis
21 ulcerative colitis21 ulcerative colitis
21 ulcerative colitis
 
IBD
IBDIBD
IBD
 
Influence of systemic conditions on the periodontium
Influence of systemic conditions on the periodontiumInfluence of systemic conditions on the periodontium
Influence of systemic conditions on the periodontium
 
Genes to Diet in Inflammatory Bowel Disease.pdf
Genes to Diet in Inflammatory Bowel Disease.pdfGenes to Diet in Inflammatory Bowel Disease.pdf
Genes to Diet in Inflammatory Bowel Disease.pdf
 
Hígado graso no alcohólico en niños y adolescentes obesos
Hígado graso no alcohólico en niños y adolescentes obesosHígado graso no alcohólico en niños y adolescentes obesos
Hígado graso no alcohólico en niños y adolescentes obesos
 
Inflammatory Bowel Disease
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Inflammatory Bowel Disease
 
Steatosis and hcv__as published
Steatosis and hcv__as publishedSteatosis and hcv__as published
Steatosis and hcv__as published
 

More from AbdelrahmanMokhtar14

More from AbdelrahmanMokhtar14 (15)

In Hospital management of DMellitus- all.pptx
In Hospital management of DMellitus- all.pptxIn Hospital management of DMellitus- all.pptx
In Hospital management of DMellitus- all.pptx
 
Inflammatory Bowel Disease DR Mokhtar.pptx
Inflammatory Bowel Disease DR Mokhtar.pptxInflammatory Bowel Disease DR Mokhtar.pptx
Inflammatory Bowel Disease DR Mokhtar.pptx
 
Jaundice clinical approach Dr Mokhtar.pptx
Jaundice clinical  approach Dr Mokhtar.pptxJaundice clinical  approach Dr Mokhtar.pptx
Jaundice clinical approach Dr Mokhtar.pptx
 
CLOSTRidium defficile lecture DR MOKHTAR.pptx
CLOSTRidium defficile lecture DR MOKHTAR.pptxCLOSTRidium defficile lecture DR MOKHTAR.pptx
CLOSTRidium defficile lecture DR MOKHTAR.pptx
 
neuroendocrine tumor Lecture - Copy.pptx
neuroendocrine tumor  Lecture  - Copy.pptxneuroendocrine tumor  Lecture  - Copy.pptx
neuroendocrine tumor Lecture - Copy.pptx
 
CHRONIC HEPATITIS a comprehensive lecture.pptx
CHRONIC HEPATITIS a comprehensive lecture.pptxCHRONIC HEPATITIS a comprehensive lecture.pptx
CHRONIC HEPATITIS a comprehensive lecture.pptx
 
IgG lecture ( autoimmune pancreatitis ) (2).pptx
IgG lecture ( autoimmune pancreatitis ) (2).pptxIgG lecture ( autoimmune pancreatitis ) (2).pptx
IgG lecture ( autoimmune pancreatitis ) (2).pptx
 
Chronic Abdominal Wall Pain and ACNES .pptx
Chronic Abdominal Wall Pain and ACNES .pptxChronic Abdominal Wall Pain and ACNES .pptx
Chronic Abdominal Wall Pain and ACNES .pptx
 
Immune tolerance a clinician approach.pptx
Immune tolerance a clinician approach.pptxImmune tolerance a clinician approach.pptx
Immune tolerance a clinician approach.pptx
 
Dr Mokhtar lecture about fluid in Ramadan.ppt
Dr Mokhtar lecture about fluid in Ramadan.pptDr Mokhtar lecture about fluid in Ramadan.ppt
Dr Mokhtar lecture about fluid in Ramadan.ppt
 
Differential Diagnosis of Hepatomegaly.pptx
Differential Diagnosis  of Hepatomegaly.pptxDifferential Diagnosis  of Hepatomegaly.pptx
Differential Diagnosis of Hepatomegaly.pptx
 
Case Scenario presentation ( Brucellosis).pptx
Case Scenario presentation ( Brucellosis).pptxCase Scenario presentation ( Brucellosis).pptx
Case Scenario presentation ( Brucellosis).pptx
 
Lipotoxicity power point lecture DR MOKHTAR.pptx
Lipotoxicity  power point lecture DR MOKHTAR.pptxLipotoxicity  power point lecture DR MOKHTAR.pptx
Lipotoxicity power point lecture DR MOKHTAR.pptx
 
Brucellosis lecture.pptx
Brucellosis lecture.pptxBrucellosis lecture.pptx
Brucellosis lecture.pptx
 
A case of Upper GI Bleeding.pptx
A case of Upper GI Bleeding.pptxA case of Upper GI Bleeding.pptx
A case of Upper GI Bleeding.pptx
 

Recently uploaded

CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
ocean4396
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 

Recently uploaded (20)

Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 

HCV & Diabetes Mellitus lecture about link.pptx

  • 1.
  • 2. NAFLD , Chronic HCV and DM Multisystem systemic diseases with hepatic flavor
  • 3.
  • 4.
  • 5. Non-alcoholic fatty liver disease, hepatitis C virus infection and type 2 diabetes: the “vicious circle”. The liver plays a pathogenic role in the development of type 2 diabetes both in the context of non-alcoholic fatty liver disease and hepatitis C virus infection through the development of systemic and hepatic insulin resistance, partly mediated by the release of multiple pro-inflammatory cytokines, diabetogenic hepatokines and reactive oxygen species. If left uncorrected, insulin resistance will eventually lead to progressive pancreatic beta cell failure in predisposed individuals. Moreover, the strong interconnection between type 2 diabetes and liver disease may result into a “vicious circle” [25] eventually leading to liver disease progression with an excess risk of liver-related, i.e., cirrhosis and hepatocellular carcinoma (HCC), and cardiovascular complications, i.e., atheroscler
  • 6.
  • 7. Review Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight Stefano Ballestri 1, Fabio Nascimbeni 2,3, Dante Romagnoli 2, Enrica Baldelli 3, Giovanni Targher 4 and Amedeo Lonardo 2,* Received: 16 February 2016; Accepted: 2 March 2016; Published: 9 March 2016
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. Nutritional Management for GORD Dr Abdel Rahman A Mokhtar Professor Internist & Gastroenterolgist Mansoura University EGYPT 2016
  • 13. Our understanding of the pathogenesis, clinical spectrum and epidemiology of GORD has continuously evolved. Historicaly
  • 14. At first, reflux was synonymous with oesophagitis and hiatus hernia. Then, it was a motility disorder, defined by sphincter or peristaltic dysfunction. Next, it was an acid-peptic disorder. Now, we see GORD emerging as a heterogeneous entity encompassing elements of all these concepts
  • 15. These developments prompted the formation of an international consensus conference, resulting in the ‘Montreal definition’ of GORD.
  • 16.
  • 17.
  • 18.
  • 19. Cowen, S. G. Therapeutic Categories Outlook (SG Cowen,2005)
  • 20. While typical GERD symptoms are balanced between comparator groups, the distribution of complications becomes progressively skewed in gender, geographic and racial distribution. *GORD symptoms are similar between Western and Middle Eastern countries, but are lower in Eastern countries. Epidemiological trends in GORD-related disorders.
  • 21. PATHOPHYSIOLOGY The earlier belief that increased gastro esophageal reflux mainly results from one dominant mechanism has been replaced by acceptance that GORD is multifactorial
  • 22. | Possible gastroesophageal reflux disease pathophysiologies
  • 23. AT Cellular level : Exposure of the oesophageal wall to the refluxate results in :
  • 24. a | An inflammatory response occurs in the squamous epithelium, induced by the release of inflammatory mediators, which
  • 25. b | Leads to the subsequent chemoattraction and infiltration of immune cells and is
  • 26. c | Followed by the proliferative response of the epithelium..
  • 27. Kandulski, A. & Malfertheiner, P. Nat. Rev. Gastroenterol. Hepatol. 9, 15–22 (2012);
  • 28. So , it is not that simple
  • 29.
  • 33.
  • 34. Gastroesophageal Pressure Gradients & GERD: The Importance of Obesity From de Vries DR et al. Am J Gastroenterol 2008;103:1349-54.
  • 35.
  • 36.
  • 39.
  • 40.
  • 41. The intestinal microbiota lies strategically at the interface of the internal and external environment of the gut. It plays several important biological roles including: aiding in digestion and absorption of nutrients from partially digested food, production of SCFA – a primary energy source for intestinal epithelial cells (IECs), stimulating immune responses by releasing ligands, and protection against enteropathogens by production of antimicrobial peptides (AMPs)
  • 42.
  • 43.
  • 44.
  • 45. Factors affecting gut microbiota
  • 46.
  • 47. Is dysbiosis of the upper-GI tract to blame for esophageal gastroesophageal reflux disease (GERD) and it’s related conditions, Barrett’s esophagus and adenocarcinoma?
  • 48. Undoubtedly, we need to eradicate virulent H. pylori in people with adverse clinical manifestations, but this conclusion cannot be generalized to all H. pylori positive subjects.
  • 49. For the past four years we’ve known that individuals with GERD have imbalances in the microbial ecology of the distal esophagus. One consequence of this microbial shift is increased levels of Gram-negative bacteria, which harbor on their cell surface an inflammatory membrane component known as lipopolysaccharides (LPS) or endotoxin
  • 50. Clinical and Translational Gastroenterology (2015) 6, e91; doi:10.1038/ctg.2015.16; published online 18 June 2015 Type1-microbiota (Gram-positive predominant) with H. pylori provides a neutral esophageal environment. Type-II microbiota (Gram-negative predominant) with loss of H. pylori invokes a pro-inflammatory state in two ways. First, loss of H. pylori allow for increased acid secretion resulting in gastroesophageal reflux disease and its sequelae. Second, predominance of Gram- negative bacteria upregulate the pro-inflammatory cascade due to the interaction between lipopolysaccharide and Toll-like receptor 4. Gut microbiota & esophageal adenocarcinoma.
  • 51. Microbiota and its influence on obesity.
  • 52. Probiotics, Prebiotics and Symbiotics Probiotics are defined as live microorganisms which confer health benefits to the host when taken in adequate quantities. Prebiotics are nondigestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of beneficial colonic bacteria. Acombination of probiotics and prebiotics is termed symbiotics. Various kinds of probiotics have been tested clinically as potential therapeutic agents for both localized and systemic diseases.
  • 53. Should dietary guidelines consider microbiota needs ???
  • 55.
  • 57. It is a common belief that some foods may induce or worsen GERD symptoms; in fact, in daily clinical practice, this belief leads to advising patients to avoid the suspect foods . Further more, since GERD symptoms are most commonly reported postprandially, the role of diet components in inducing symptoms has been suggested. However, different and conflicting results exist in the literature for identifying the most “refluxogenic” foods Festi etal.,World J Gastroenterol April 14, 2009
  • 58. Dietary elements may ppt reflux episode via : Increasing acid secretion e.g Coffee. Decrease LOS pressure e.g peppermint & ess oils. Slow gastric emptying e.g fatty food . Impairing oesophageal motility e.g alcohol. Triggering pain by irritating an already inflammed oesophageal mucosa e.g Tomato, citrus, softdrinksandspicyfood.
  • 59. Foods Not Recommended It is recommended that a trial of limiting or eliminating the following foods may reduce the symptoms of GERD: • Peppermint and spearmint • Chocolate • Alcohol • Caffeinated beverages (regular tea, coffee, colas, energy drinks, other caffeinated soft drinks) • Decaffeinated coffee and decaffeinated regular tea (herbal teas, except those with peppermint or spearmint, are allowed) • Pepper • High-fat foods, including: o 2% milk, whole milk, cream, high-fat cheeses, high-fat yogurt, chocolate milk, cocoa o Fried meats, bacon, sausage, pepperoni, salami, bologna, frankfurters/hot dogs o Other fried foods (doughnuts, french toast, french fries, deep-fried vegetables) o Nuts and nut butters o Pastries and other high-fat desserts o More than 8 teaspoons of oil, butter, shortening per day • Any fruits or vegetables that cause symptoms. (These will vary from person to person.) American Dietetic Association.
  • 60. Other Lifestyle Tips • Exercise at least three or four times each week. • Wear loose-fitting clothes. • Do not smoke. • Raise the head of your bed 6 to 9 inches. You can put a foam wedge under the top part of the mattress, or prop up the legs on the head of the bed with wooden blocks. (Stacking pillows is not effective.) • Wait 3 hours after eating before lying down. • Eat several small meals throughout the day. • Eat in a calm, relaxed place. Sit down while you eat.
  • 63.